Gentium SpA (fka GENTY)

[surf1944]

6:12AM Gentium receives Marketing Authorization from the European Commission for Defitelio (GENT) 29.59 : Co announced that the European Commission has granted a Marketing Authorization for Defitelio (defibrotide) for the treatment of severe hepatic veno-occlusive disease ("VOD") in adults and children undergoing hematopoietic stem cell transplantation therapy. Defitelio is the first approved treatment in the European Union for this lcondition. This authorization is the formal endorsement of the positive opinion received from the European Medicine Agency's Committee for Human Medicinal Producton July 26, 2013. The Company intends to begin commercialization of Defitelio in the European Union in December 2013.